Copy For Citation
KARADAĞ Ö., DALKILIÇ H. E., AYAN G., KÜÇÜKŞAHİN O., KAŞİFOĞLU T., Yilmaz N., ...More
CLINICAL RHEUMATOLOGY, vol.41, no.1, pp.85-94, 2022 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
41
Issue:
1
-
Publication Date:
2022
-
Doi Number:
10.1007/s10067-021-05893-3
-
Journal Name:
CLINICAL RHEUMATOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
-
Page Numbers:
pp.85-94
-
Keywords:
Anti-TNF, ACR20/50/70, DAPSA28, DAS28, Psoriatic arthritis, Work disability, CERTOLIZUMAB PEGOL, CLINICAL-RESPONSE, DISEASE-ACTIVITY, DOUBLE-BLIND, PHASE-III, GOLIMUMAB, SAFETY, TRIAL, MULTICENTER, ETANERCEPT
-
Hacettepe University Affiliated:
Yes
Abstract
Objectives To understand change in work productivity, activity impairment, quality of life (QoL), and disease activity in patients with psoriatic arthritis (PsA) receiving anti-tumor necrosis factor (anti-TNF) treatment.